Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.

Journal of Gastroenterology
Masaya SaitoTakeshi Azuma

Abstract

Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular carcinoma (HCC) that can cause deterioration of liver function. We aimed to make an early predictive model of long-term liver dysfunction after TACE. We performed a prospective cohort study involving 109 HCC patients who underwent TACE at Kobe University Hospital. Indirect calorimetry and blood biochemical examinations were performed before and 7 days after TACE. As an indicator of liver function, the Child's score was evaluated before and 3 months after TACE. Patients with and without Child's score deterioration were compared, and the independent risk factors for Child's score deterioration were statistically examined. An early predictive model of Child's score deterioration after TACE was developed using multivariate logistic regression. Multivariate analyses showed that the non-protein respiratory quotient (npRQ) and prealbumin (preAlb) ratios (7 days after/before TACE) were independent determinants of Child's score deterioration (p = 0.039 and 0.020, respectively). Decreases of the npRQ and preAlb ratios were significantly related to increases of Child's score 3 months after TACE (p = 0.007 and 0.002, respectively). The following pr...Continue Reading

References

Apr 1, 1992·American Journal of Surgery·H BismuthA Roche
Jun 1, 1992·The Clinical Investigator·H U LautzM J Müller
May 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M J MüllerF W Schmidt
Mar 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D VetterR Bockel
Jun 1, 1990·Cardiovascular and Interventional Radiology·R YamadaM Satoh
Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Nov 1, 1983·The Journal of Clinical Investigation·O E OwenG Boden
May 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L MondazziG Idèo
Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Apr 1, 1996·The American Journal of Clinical Nutrition·L CaregaroA Gatta
Dec 1, 1996·Journal of Clinical Epidemiology·P PeduzziA R Feinstein
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P S KamathW R Kim
Mar 8, 2002·Nutrition·Masahiro TajikaHisataka Moriwaki
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chung-Mau LoJohn Wong
Jan 4, 2003·Gastroenterology·Russell WiesnerUNKNOWN United Network for Organ Sharing Liver Disease Severity Score Committee
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Feb 18, 2005·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masako TsuchiyaKiwamu Okita
Jun 1, 1994·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·M J MüllerO Selberg
Jan 20, 2007·Nutrition·Yutaka NakayaUNKNOWN Hepatic Nutritional Therapy (HNT) Study Group
Jan 1, 2010·Journal of Nutritional Science and Vitaminology·Yoichi TerakuraHisataka Moriwaki

❮ Previous
Next ❯

Citations

Oct 28, 2016·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Jia NingHuijun Chen
Mar 14, 2018·ANZ Journal of Surgery·Tatsuo ShimuraShigeru Marubashi
Nov 20, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hiroki NishikawaShuhei Nishiguchi
Oct 16, 2018·Molecular Medicine Reports·Qiuping GuoWei Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.